Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

INTRODUCTION: Multiple myeloma (MM) is a relatively common and incurable hematological malignancy. Currently, there is no single standard therapy, with choice of treatment dependent on individual patient factors. Lenalidomide is an immunomodulatory drug with potent antitumor, antiangiogenic, immunom...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, Paul, Mitsiades, Constantine, Laubach, Jacob, Schlossman, Robert, Ghobrial, Irene, Hideshima, Teru, Munshi, Nikhil, Anderson, Kenneth
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899783/
https://www.ncbi.nlm.nih.gov/pubmed/20694078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899783/
https://www.ncbi.nlm.nih.gov/pubmed/20694078

Ejemplares similares